Polycystic Ovary Syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group: The intervention group receives magnesium supplements twice a day in the form of magnesium oxide tablets (each tablet contains 250 mg of elemental magnesium). Inter
Sponsors
Bojnourd University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Infertility for more than a year Absence of acute and chronic diseases, Not using medicinal compounds and supplements containing magnesium. Not taking anti-anxiety and sedative drugs. Not using drugs, tobacco and alcohol. Not using relaxation techniques. Body mass index less than 35, Magnesium intake less than 75% of the recommended dietary intake
Exclusion criteria
Exclusion criteria: Pregnancy, Use of oral contraceptive pills, Occurrence of any severe stress (for example, divorce or death of a relative), Personal desire to withdraw from the study during the study, Consumption of less than 90 out of 112 magnesium supplement tablets or placebo.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the effect of magnesium supplementation on stress and ovulation rate in infertile women with polycystic ovary syndrome. Timepoint: Newton's stress questionnaire first and then 4 weeks after taking the pills and at the end of taking the pills.Vaginal ultrasound at the beginning of the study as an entry criterion and then 4 weeks after taking the pills and then between the 10th and 14th day of the trigger drug cycle. Method of measurement: Ultrasound, Newton stress questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Hassanzadeh Bashtian
Bojnourd University of Medical Sciences
Outcome results
None listed